Shuguang Zeng

Prof. Dr. Shuguang Zeng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2020 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
ZLZhao Liu
Zhao Liu
YHYiheng He
Yiheng He
CXChenrong Xu
Chenrong Xu
JLJianjia Li
Jianjia Li
SZShuguang Zeng
Shuguang Zeng
QHQianqian Han
Qianqian Han

18 May 2021 in Stem Cells International
Verified
Journal Article
Open access
PDF file
LZLifang Zhang
Lifang Zhang
XLXinping Li
Xinping Li
CSCongying Shi
Congying Shi
GRGaoying Ran
Gaoying Ran
YPYuting Peng
Yuting Peng
YHYan He
Yan He
Angiogenesis in the field of tissue engineering has attracted significant attention. Graphene oxide has become a promising nanomaterial in tissue engineering for its unique biochemical properties. Therefore, herein, a series of chitosan (CS)/graphene oxide (GO) hydrogel scaffolds were synthesized by crosslinking CS and GO at different concentrations (0.1, 0.5, and 1.0 wt.%) using genipin. Compared with the CS hydrogel scaffolds, the CS/GO hydrogel scaffolds have a better network structure and mechanical strength. Then, we used endothelial progenitor cells (EPCs) extracted from human umbilical cord blood and cocultured these EPCs with the as-prepared scaffolds. The scaffolds with 0.1 and 0.5 wt.%GO showed no considerable cytotoxicity, could promote the proliferation of EPCs and tube formation, and upregulated the expressions of CD34, VEGF, MMP9, and SDF-1 in EPCs compared to the case of the scaffold with 1.0 wt.%GO. This study shows that the addition of graphene oxide improves the structure of chitosan hydrogel and enhances the proliferation activity and angiogenic capacity of EPCs.

1 December 2021 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
GRGaoying Ran
Gaoying Ran
WFWei Fang
Wei Fang
LZLifang Zhang
Lifang Zhang
YPYuting Peng
Yuting Peng
AWAnbiao Wu
Anbiao Wu
YHYan He
Yan He

20 October 2022 in Chinese Astronomy and Astrophysics
Verified
Journal Article
Open access
Bo JiangBo Jiang
Bo Jiang
LLLei Liu
Lei Liu
ZSZheng Sheng
Zheng Sheng
YSYang Shan-Shan
Yang Shan-Shan
SZShuguang Zeng
Shuguang Zeng
L罗luoxiaoyu 罗
luoxiaoyu 罗

25 September 2025 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
YCYunbing Chen
Yunbing Chen
XLXinping Li
Xinping Li
HYHongyi Yang
Hongyi Yang
GRGaoying Ran
Gaoying Ran
LZLifang Zhang
Lifang Zhang
SZShuguang Zeng
Shuguang Zeng

10 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
GRGaoying Ran
Gaoying Ran
WFWei Fang
Wei Fang
LZLifang Zhang
Lifang Zhang
YPYuting Peng
Yuting Peng
JLJiatong Li
Jiatong Li
YHYan He
Yan He
Objectives Insulin-like growth factor-1 (IGF-1) and bone morphogenetic protein 2 (BMP-2) both promote osteogenesis of bone marrow mesenchymal stem cells (BMSCs). IGF-1C, the C domain peptide of IGF-1, and P24, a BMP-2-derived peptide, both have similar biological activities as their parent growth factors. This study aimed to investigate the effects and their mechanisms of polypeptides IGF-1C and P24 on the osteogenic differentiation of BMSCs. Methods The optimum concentrations of IGF-IC and P24 were explored. The effects of the two polypeptides on the proliferation and osteogenic differentiation of BMSCs were examined using the Cell Counting Kit-8(CCK-8), Alkaline phosphatase (ALP) staining, ALP activity assay, alizarin red S staining, qPCR, and western blotting. In addition, specific pathway inhibitors were utilized to explore whether p38 and JNK pathways were involved in this process. Results The optimal concentrations of action were both 50 μg/ml. IGF-1C and P24 synergistically promoted the proliferation of BMSCs, increased ALP activity and the formation of calcified nodules and upregulated the mRNA and protein levels of osterix (Osx), runt-related transcription factor 2 (Runx2), and osteocalcin (Ocn), phosphorylation level of p38 and JNK proteins also improved. Inhibition of the pathways significantly reduced the activation of p38 and JNK, blocked the expression of Runx2 while inhibiting ALP activity and the formation of calcified nodules. Conclusions These findings suggest IGF-1C and P24 synergistically promote the osteogenesis of BMSCs through activation of p38 and JNK signal pathways.